The document discusses bionic eyes, which are devices that can partially restore central vision for those who are blind due to advanced retinitis pigmentosa or choroideremia. It describes two main types of bionic eyes: Alpha-IMS, which uses a microchip and electrode array implanted in the retina, and Argus II, which uses a camera and transmitter outside the eye that sends signals to an implant. The document outlines challenges with bionic eyes like surgical risks and issues with resolution. It also notes goals of improving resolution, adding color detection, increasing cases where implantation is possible, and reducing clinical issues.